556 related articles for article (PubMed ID: 15676215)
21. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
[TBL] [Abstract][Full Text] [Related]
22. The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts.
Mumcuoglu M; Zakay-Rones Z; Parag G; Weiss L; Slavin S
Bone Marrow Transplant; 1987 Dec; 2(4):403-12. PubMed ID: 3332187
[TBL] [Abstract][Full Text] [Related]
23. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
Eyrich M; Leiler C; Lang P; Schilbach K; Schumm M; Bader P; Greil J; Klingebiel T; Handgretinger R; Niethammer D; Schlegel PG
Bone Marrow Transplant; 2003 Aug; 32(4):379-90. PubMed ID: 12900774
[TBL] [Abstract][Full Text] [Related]
24. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
Makrynikola V; Kabral A; Bradstock KF
Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
[TBL] [Abstract][Full Text] [Related]
25. Use of gene marking in bone marrow transplantation.
Heslop HE; Rooney CM; Rill DR; Krance RA; Brenner MK
Cancer Detect Prev; 1996; 20(2):108-13. PubMed ID: 8706035
[TBL] [Abstract][Full Text] [Related]
26. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis.
Reiffers J; Labopin M; Sanz M; Korbling M; Blaise D; De La Rubia J; Gorin NC
Bone Marrow Transplant; 2000 Jun; 25(11):1115-9. PubMed ID: 10849522
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological-mediated purging with mafosfamide in acute and chronic myeloid leukemias. The Italian Study Group.
Rizzoli V; Mangoni L
Prog Clin Biol Res; 1990; 333():21-36; discussion 37-8. PubMed ID: 2308982
[TBL] [Abstract][Full Text] [Related]
28. Alteration of the T cell repertoire after bone marrow transplantation.
Villers D; Milpied N; Gaschet J; Davodeau F; Hallet MM; Bonneville M; Vié H
Bone Marrow Transplant; 1994 Jan; 13(1):19-26. PubMed ID: 8019449
[TBL] [Abstract][Full Text] [Related]
29. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide.
Perot C; van den Akker J; Laporte JP; Douay L; Lopez M; Stachowiak J; Isnard F; Taillemite JL; Najman A; Gorin NC
Leukemia; 1993 Apr; 7(4):509-15. PubMed ID: 8464228
[TBL] [Abstract][Full Text] [Related]
30. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
Gidáli J; Fehér I
Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
[TBL] [Abstract][Full Text] [Related]
31. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
[TBL] [Abstract][Full Text] [Related]
32. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
[TBL] [Abstract][Full Text] [Related]
33. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
Morishima Y
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
[TBL] [Abstract][Full Text] [Related]
34. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
Martin H; Bruecher J; Claudé R; Hoelzer D
Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
[TBL] [Abstract][Full Text] [Related]
35. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
Skórski T; Kawalec M
Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
[TBL] [Abstract][Full Text] [Related]
36. Developments in purging in autotransplantation.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1993 Jun; 7(3):687-715. PubMed ID: 8344886
[TBL] [Abstract][Full Text] [Related]
37. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
38. Purging with 4-hydroperoxycyclophosphamide.
Jones RJ
J Hematother; 1992; 1(4):343-8. PubMed ID: 1345676
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo expansion of mafosfamide-purged PBPC products.
McNiece I; Civin C; Harrington J; Kellner J; Malehorn M; Turney J; Barber J; Jones R
Cytotherapy; 2006; 8(5):459-64. PubMed ID: 17050250
[TBL] [Abstract][Full Text] [Related]
40. [A study of T-cell reconstitution after HLA-matched sibling bone marrow transplantation in leukemia patients].
Fu YW; Wu DP; Cen JN; Feng YF; Zhu ZL; Zhu P
Zhonghua Nei Ke Za Zhi; 2007 Sep; 46(9):743-6. PubMed ID: 18028804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
